Project Grant HT94252410208
- Mayo Clinic was awarded a $8,966,819 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from July 1, 2023 to June 30, 2027 to further develop purified exosome products for treating pulmonary damage from toxic exposures, leveraging Mayo Clinic's expertise in exosome applications. Through this funding, Mayo Clinic aims to advance biomedical solutions applicable to both military and civilian...
- The U.S. Defense Health Agency has awarded a $1,187,875 Project Grant to Mayo Clinic to support the research project "INVESTIGATING MOLECULAR MECHANISMS UNDERLYING THE CILIARY TRAFFICKING OF POLYCYSTINS". This grant, awarded on April 1, 2024 under the Military Medical Research and Development program (CFDA 12.420), will fund research to advance the understanding of the molecular mechanisms involved in the trafficking of polycystins through cellular cilia. The project aims to yield...
- The Mayo Clinic was awarded a $1,605,726.00 Cooperative Agreement from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to provide treatment of pulmonary insults from acute and chronic toxic exposures using purified exosome products. The project aims to investigate medical solutions for the battlefield through innovative and impactful research focused on transforming health care for Service Members and the American public. The 3-year project...
- The federal Project Grant award of $161,400.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will support Mayo Clinic's research project titled "AN ATLAS OF THE TUMOR IMMUNE CIRCULOME." This award, with a performance period from June 1, 2024 to May 31, 2025, aims to advance medical knowledge and improve patient care through innovative biomedical research. The Military Medical Research and Development program funds a wide range of...
- This federal Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to Mayo Clinic provides $1,443,639.00 to investigate the molecular mechanisms underlying the ciliary trafficking of polycystins. The grant has an award date of April 1, 2024 and a planned completion date of March 31, 2028. This research seeks to advance the understanding of diseases related to ciliary dysfunction, which may have important implications for military medicine....
- Federal Grant Award Summary Mayo Clinic received a $424,565 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, through August 31, 2028. The grant funds research on the clinical significance of somatic genetic variants in telomere biology disorders, conducted at Mayo Clinic's Rochester, Minnesota facility. This three-year research initiative aligns with the Defense Health Agency's mission to...
- The U.S. Defense Health Agency awarded a $1,210,500 Project Grant to the Mayo Clinic in Rochester, Minnesota under the Military Medical Research and Development program (CFDA 12.420). The grant supports a 3-year research project titled "Exploring Novel ALS Biomarkers: Multiomics Approach Utilizing Immunoprofiling, Extracellular Vesicle Analysis, and TDP-43 Aggregation Assays." The research aims to develop innovative diagnostic tools and advance the understanding of amyotrophic...
- The Defense Health Agency awarded Mayo Clinic Jacksonville $3,232,027 under the Military Medical Research and Development federal grant program (CFDA 12.420) from September 15, 2023 through September 14, 2027. Through this award, Mayo Clinic will integrate molecular pathology, radiology, and genetics to improve breast cancer risk prediction. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform health care for service members...
- The Defense Health Agency awarded a $597,543.00 Project Grant to Mayo Clinic Arizona, doing business as Mayo Clinic Hospital, a nonprofit academic medical center. The grant, which runs from October 1, 2023 to September 14, 2026, is funded under the Military Medical Research and Development program (CFDA 12.420) to support research aimed at "elucidating mechanisms of CAR-T cell immunotherapy resistance and sensitivity to improve treatment of myeloma." As a nonprofit organization with...
- Federal Grant Award Summary Mayo Clinic received a $564,900 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) on October 15, 2025, with a completion date of October 14, 2027. The award supports research targeting the distinct immune microenvironments of intrahepatic and perihilar/distal cholangiocarcinoma. This research initiative aligns with the Defense Health Agency's mission to advance biomedical research that...
The Department of Defense's Defense Health Agency awarded a $322,800 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Mayo Clinic in Rochester, Minnesota. The grant, with a performance period from April 1, 2024 to March 31, 2026, supports research on "MYELOPEROXIDASE PROMOTES PERSISTENT FIBROSIS." As a renowned non-profit academic medical center, Mayo Clinic will leverage its expertise in clinical care, biomedical research, and medical education to advance this project focused on understanding the role of myeloperoxidase in chronic fibrotic conditions. The funding will enable Mayo Clinic to conduct basic, translational, and potentially clinical research to investigate new approaches for addressing persistent fibrosis, which is a critical priority for the military medical community.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $322.8k | 2/23/24 |